Showing results (51-60 of 88) with videos related to
Sort By:
Pageof 9
The Journal of Infectious Diseases|February 1, 2011
Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trialJacques Fellay, Nicole Frahm, Kevin V Shianna, et al.Plos One|January 6, 2011
Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locusChul-Woo Pyo, Lisbeth A Guethlein, Quyen Vu, et al.Biorxiv : the Preprint Server for Biology|June 23, 2021
Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 - 2021/03) Using a Statistical Learning StrategyLue Ping Zhao, Terry P Lybrand, Peter B Gilbert, et al.Viruses|January 22, 2022
Tracking SARS-CoV-2 Spike Protein Mutations in the United States (January 2020-March 2021) Using a Statistical Learning StrategyLue Ping Zhao, Terry P Lybrand, Peter B Gilbert, et al.JCI Insight|March 4, 2025
Two DRB3 residues predictively associate with the progression to type 1 diabetes among DR3 carriersLue Ping Zhao, George K Papadopoulos, Jay S Skyler, et al.The Journal of Infectious Diseases|July 24, 2013
Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infectionHolly Janes, David P Friedrich, Amy Krambrink, et al.Frontiers in Immunology|December 6, 2021
A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell TransplantationPaul J Martin, David M Levine, Barry E Storer, et al.Diabetes Care|May 27, 2022
Association of HLA-DQ Heterodimer Residues -18β and β57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial-Type 1Lue Ping Zhao, Jay Skyler, George K Papadopoulos, et al.Journal of Virology|February 12, 2010
Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotypeWarren L Dinges, Julia Richardt, David Friedrich, et al.Diabetes Care|July 1, 2024
Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07)Lue Ping Zhao, George K Papadopoulos, Jay S Skyler, et al.Pageof 9